Project Details
| Status | Active |
|---|---|
| Effective start/end date | 11/14/23 → 11/14/26 |
Funding
- PPD Investigator Services, LLC (Prot # TAK-012-1501 // Prot # TAK-012-1501)
- Takeda Development Center Americas, Inc. (Prot # TAK-012-1501 // Prot # TAK-012-1501)
Prot #TAK-012-1501: A Phase 1/2a, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety and Efficacy of GDX012 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Altman, Jessica K (PD/PI)
Project: Research project